Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.930,57
1,66%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Solid Biosciences Inc (SLDB) Solid Biosciences Inc (SLDB) Notizie

Solid Biosciences Inc

SLDB
10,10
-0,13 (-1,27%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202422:05GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
03/4/202422:05GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
01/4/202413:45GLOBESolid Biosciences Receives Rare Pediatric Disease..
27/3/202412:00GLOBESolid Biosciences to Participate at Cantor’s Virtual..
13/3/202412:44GLOBESolid Biosciences Provides Fourth Quarter and Full-Year 2023..
07/3/202413:00GLOBESolid Biosciences Announces Licensing Agreement with Armatus..
06/3/202414:00GLOBESolid Biosciences to Participate at Upcoming Investor..
16/2/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202417:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
30/1/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202422:09EDGAR2Form S-3 - Registration statement under Securities Act of..
16/1/202414:50DJNSolid Biosciences Gets Orphan Drug Designation for SGT-003
16/1/202414:00GLOBESolid Biosciences Granted FDA Orphan Drug Designation for..
12/1/202423:05EDGAR2Form SC 13D/A - General statement of acquisition of..
11/1/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:31EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202413:24EDGAR2Form 8-K - Current report
08/1/202413:09GLOBESolid Biosciences Announces $109 Million Private Placement
06/1/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202414:00GLOBESolid Biosciences to Participate at 42nd Annual J.P. Morgan..
07/12/202316:49DJNSolid Biosciences Shares Jump After FDA Fast-Tracks SGT-0003
07/12/202314:00GLOBESolid Biosciences Receives FDA Fast Track Designation for..
05/12/202320:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202320:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202314:00GLOBESolid Biosciences to Participate at 35th Annual Piper..
15/11/202314:51IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
15/11/202313:59EDGAR2Form 8-K - Current report
14/11/202322:05GLOBESolid Biosciences Announces IND Clearance by FDA for..
09/11/202314:00GLOBESolid Biosciences to Participate at Jefferies London..
08/11/202322:17GLOBESolid Biosciences Provides Third Quarter Business Update and..
08/11/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/10/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202322:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202314:00GLOBESolid Biosciences Appoints Gabriel Brooks, M.D., as Chief..
20/9/202314:00GLOBESolid Biosciences to Participate at Upcoming Investor..
06/9/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202314:56GLOBESolid Biosciences to Participate at Upcoming Investor..
31/8/202314:00GLOBESolid Biosciences to Participate in Citi’s 18th Annual..
14/8/202322:17GLOBESolid Biosciences Provides Second Quarter Business Update..
14/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/6/202314:00GLOBESolid Biosciences to Participate at the Jefferies Healthcare..
22/5/202314:00GLOBESolid Biosciences to Participate at the Barclays Gene..
16/5/202314:00GLOBESolid Biosciences to Present at the American Society of Gene..
Apertura: 10,33 Min: 10,02 Max: 10,70
Chiusura: 10,23

La tua Cronologia

NASDAQ
SLDB
Solid Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network